Search research articles
Contact Us
Filters
Showing results (221-230 of 244) with videos related to
Page
of 25
Sort By:
Bulletin Du Cancer
|
January 22, 1998
[Intensive chemotherapy with autologous stem cell transplantation in ovarian cancers: analysis of 67 patients treated at the Paoli-Calmettes Institute and a review of the literature]
P Viens, F Bertucci, G Gravis, et al.
BMC Cancer
|
October 16, 2015
Immunohistochemical subtypes predict the clinical outcome in high-risk node-negative breast cancer patients treated with adjuvant FEC regimen: results of a single-center retrospective study
S Rahal, J M Boher, J M Extra, et al.
Bone Marrow Transplantation
|
July 5, 2011
Randomized study of early hospital discharge following autologous blood SCT: medical outcomes and hospital costs
C Faucher, A G Le Corroller Soriano, B Esterni, et al.
Oncogene
|
July 5, 2006
Correlated break at PARK2/FRA6E and loss of AF-6/Afadin protein expression are associated with poor outcome in breast cancer
A Letessier, S Garrido-Urbani, C Ginestier, et al.
International Journal of Oncology
|
July 31, 1999
Production of ex vivo expanded hematopoietic cells and progenitors in a closed bioreactor, starting with a small volume marrow collection: A feasibility study in patients with poor-risk breast cancer and receiving high-doses of cyclophosphamide
C Chabannon, J L Blache, I Sielleur, et al.
Oncogene
|
September 28, 2005
Postoperative serum proteomic profiles may predict metastatic relapse in high-risk primary breast cancer patients receiving adjuvant chemotherapy
A Gonçalves, B Esterni, F Bertucci, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 3, 2012
Comparison of the prognostic value of genomic grade index, Ki67 expression and mitotic activity index in early node-positive breast cancer patients
F Bertucci, P Finetti, H Roche, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 22, 2016
Nectin-4: a new prognostic biomarker for efficient therapeutic targeting of primary and metastatic triple-negative breast cancer
M M-Rabet, O Cabaud, E Josselin, et al.
Leukemia
|
April 12, 2003
Cost-effectiveness of repeated aphereses in poor mobilizers undergoing high-dose chemotherapy and autologous hematopoietic cell transplantation
C Chabannon, A-G Le Corroller, F Viret, et al.
Leukemia
|
August 22, 2003
Infectious complications following allogeneic HLA-identical sibling transplantation with antithymocyte globulin-based reduced intensity preparative regimen
M Mohty, W Jacot, C Faucher, et al.
Page
of 25
Search research articles
Search
Showing results (221-230 of 244) with videos related to
Sort By:
Page
of 25
Bulletin Du Cancer
|
January 22, 1998
[Intensive chemotherapy with autologous stem cell transplantation in ovarian cancers: analysis of 67 patients treated at the Paoli-Calmettes Institute and a review of the literature]
P Viens, F Bertucci, G Gravis, et al.
BMC Cancer
|
October 16, 2015
Immunohistochemical subtypes predict the clinical outcome in high-risk node-negative breast cancer patients treated with adjuvant FEC regimen: results of a single-center retrospective study
S Rahal, J M Boher, J M Extra, et al.
Bone Marrow Transplantation
|
July 5, 2011
Randomized study of early hospital discharge following autologous blood SCT: medical outcomes and hospital costs
C Faucher, A G Le Corroller Soriano, B Esterni, et al.
Oncogene
|
July 5, 2006
Correlated break at PARK2/FRA6E and loss of AF-6/Afadin protein expression are associated with poor outcome in breast cancer
A Letessier, S Garrido-Urbani, C Ginestier, et al.
International Journal of Oncology
|
July 31, 1999
Production of ex vivo expanded hematopoietic cells and progenitors in a closed bioreactor, starting with a small volume marrow collection: A feasibility study in patients with poor-risk breast cancer and receiving high-doses of cyclophosphamide
C Chabannon, J L Blache, I Sielleur, et al.
Oncogene
|
September 28, 2005
Postoperative serum proteomic profiles may predict metastatic relapse in high-risk primary breast cancer patients receiving adjuvant chemotherapy
A Gonçalves, B Esterni, F Bertucci, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 3, 2012
Comparison of the prognostic value of genomic grade index, Ki67 expression and mitotic activity index in early node-positive breast cancer patients
F Bertucci, P Finetti, H Roche, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 22, 2016
Nectin-4: a new prognostic biomarker for efficient therapeutic targeting of primary and metastatic triple-negative breast cancer
M M-Rabet, O Cabaud, E Josselin, et al.
Leukemia
|
April 12, 2003
Cost-effectiveness of repeated aphereses in poor mobilizers undergoing high-dose chemotherapy and autologous hematopoietic cell transplantation
C Chabannon, A-G Le Corroller, F Viret, et al.
Leukemia
|
August 22, 2003
Infectious complications following allogeneic HLA-identical sibling transplantation with antithymocyte globulin-based reduced intensity preparative regimen
M Mohty, W Jacot, C Faucher, et al.
Page
of 25